抗生素类型和时间与败血症死亡率的关联,使用目标试验仿真
Jiayang Li1, Mingyi Zhao2, Qingnan He3
1Department of Pediatrics, The Third Xiangya Hospital of Central South University, No. 172, Tongzipo Road, Changsha, 410011, Hunan, People's Republic of China.
Scientific reports
|February 25, 2026
概括
经验性β-lactam抗生素改善了重症监护室 (ICU) 败血症患者的生存率. 在48小时内早期启动至关重要,但在这个窗口内的时间并没有显著改变结果.
科学领域:
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 败血症的治疗需要及时的抗生素治疗.
- 最佳的经验抗生素选择和败血症的时间被争论.
- 患有败血症的重症监护室 (ICU) 患者面临高死亡风险.
研究的目的:
- 评估一线抗生素选择对ICU血症患者住院死亡率的影响.
- 评估抗生素开始时间对败血症结果的影响.
- 为了确定β-lactam偏好是否影响败血症的生存率.
主要方法:
- 利用MIMIC-IV数据库模拟一个连续的目标试验.
- 采用克隆-传感器-权重方法来近似随机化和解决混.
- 分析了使用加权考克斯回归和灵敏度分析的住院死亡率.
主要成果:
- 贝塔乳酸抗生素的使用与医院内死亡率显著降低相关 (HR 0.88).
- 在7,14,60天的随访期间,β-乳对生存的益处是一致的.
- 在48小时窗口内启动抗生素的时间没有显著影响β-乳酸盐或糖的结果.
结论:
- 经验性β-lactam疗法与ICU败血症中改善的生存率有关.
- 支持优先考虑β-乳疗法作为早期败血症的第一线实证治疗.
- 虽然早期启动是关键,但在48小时内特定的时间没有对结果产生差异性影响.
更多相关视频
相关概念视频
Comparing the Survival Analysis of Two or More Groups
674
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
674
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
232
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
232
Combined Effects of Drugs: Synergism
7.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.1K
Antimicrobial Effectiveness
1.4K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.4K


